Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Protein injection points to muscular dystrophy treatment

27.11.2012
Scientists have discovered that injecting a novel human protein into muscle affected by Duchenne muscular dystrophy significantly increases its size and strength, findings that could lead to a therapy akin to the use of insulin by diabetics.

These results were published today in the Proceedings of the National Academy of Sciences by Dr. Julia von Maltzahn and Dr. Michael Rudnicki, the Ottawa scientist who discovered muscle stem cells in adults.

"This is an unprecedented and dramatic restoration in muscle strength," says Dr. Rudnicki, a senior scientist and director for the Regenerative Medicine Program and Sprott Centre for Stem Cell Research at the Ottawa Hospital Research Institute. He is also a Canada Research Chair in Molecular Genetics and professor in the Faculty of Medicine at the University of Ottawa.

"We know from our previous work that this protein, called Wnt7a, promotes the growth and repair of healthy muscle tissue. In this study we show the same types of improvement in a mouse model of Duchenne muscular dystrophy. We found that Wnt7a injections increased muscle strength almost two-fold, to nearly normal levels. We also found that the size of the muscle fibre increased and there was less muscle damage, compared to mice not given Wnt7a."

Duchenne muscular dystrophy is a genetic disorder that affects one of every 3,500 newborn males. In Canada, all types of muscular dystrophy affect more than 50,000 people. The disease often progresses to a state where the muscles are so depleted that the person dies due to an inability to breath. For people with Duchenne muscular dystrophy, this usually happens in their 20s or 30s.

"This is also exciting because we think it's a therapeutic approach that could apply to other muscle-wasting diseases," says Dr. Rudnicki.

Dr. Rudnicki's lab is a world leader in research on muscle stem cells. They have contributed significantly to our understanding of how these cells work at the molecular level. This basic research, which takes place in OHRI's multidisciplinary environment of collaboration with clinicians, led to the identification of Wnt7a as a promising candidate to help people with this muscle wasting disease.

Biotechnology partner, Fate Therapeutics is currently developing Wnt7a-based therapeutic candidates for treatment of muscular dystrophy and atrophy. Preclinical assessments are ongoing and the company plans to initiate clinical trials in the near future.

The full article, "Wnt7a treatment ameliorates muscular dystrophy," is available online ahead of print through the Proceedings of the National Academy of Sciences site.

This research was supported by the Muscular Dystrophy Association, the Ontario Ministry of Economic Development and Innovation, the Canadian Institutes of Health Research, the National Institutes of Health, the Howard Hughes Medical Institute, Fate Therapeutics and the Canada Research Chair Program. All research at OHRI is also supported by The Ottawa Hospital Foundation.

Media Contact
Paddy Moore
Manager, Communications and Public Relations,
Ottawa Hospital Research Institute
613-798-5555 ext. 73687
613-794-6912 (cell)
padmoore@ohri.ca
Néomie Duval
Media Relations Officer
University of Ottawa
613-562-5800 x2981
613-863-7221 (cell)
neomie.duval@uOttawa.ca
About the Ottawa Hospital Research Institute (OHRI)

The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university's Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease. Research at OHRI is supported by The Ottawa Hospital Foundation. www.ohri.ca
About the University of Ottawa

The University of Ottawa is committed to research excellence and encourages an interdisciplinary approach to knowledge creation, which attracts the best academic talent from across Canada and around the world. It is an important stakeholder in the National Capital Region's economic development.

Paddy Moore | EurekAlert!
Further information:
http://www.ohri.ca

More articles from Health and Medicine:

nachricht Using fragment-based approaches to discover new antibiotics
21.06.2018 | SLAS (Society for Laboratory Automation and Screening)

nachricht Scientists learn more about how gene linked to autism affects brain
19.06.2018 | Cincinnati Children's Hospital Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: IT-Sicherheit beim autonomen Fahren

FH St. Pölten entwickelt neue Methode für sicheren Informationsaustausch zwischen Fahrzeugen mittels Funkdaten

Neue technische Errungenschaften wie das Internet der Dinge oder die direkte drahtlose Kommunikation zwischen Objekten erhöhen den Bedarf an effizienter...

Im Focus: Innovative Handprothesensteuerung besteht Alltagstest

Selbstlernende Steuerung für Handprothesen entwickelt. Neues Verfahren lässt Patienten natürlichere Bewegungen gleichzeitig in zwei Achsen durchführen. Forscher der Universitätsmedizin Göttingen (UMG) veröffentlichen Studie im Wissenschaftsmagazin „Science Robotics“ vom 20. Juni 2018.

Motorisierte Handprothesen sind mittlerweile Stand der Technik bei der Versorgung von Amputationen an der oberen Extremität. Bislang erlauben sie allerdings...

Im Focus: Temperaturgesteuerte Faser-Lichtquelle mit flüssigem Kern

Die moderne medizinische Bildgebung und neue spektroskopische Verfahren benötigen faserbasierte Lichtquellen, die breitbandiges Laserlicht im nahen und mittleren Infrarotbereich erzeugen. Wissenschaftlerinnen und Wissenschaftler des Leibniz-Instituts für Photonische Technologien Jena (Leibniz-IPHT) zeigen in einer aktuellen Veröffentlichung im renommierten Fachblatt Optica, dass sie die optischen Eigenschaften flüssigkeitsgefüllter Fasern und damit die Bandbreite des Laserlichts gezielt über die Umgebungstemperatur steuern können.

Das Besondere an den untersuchten Fasern ist ihr Kern. Er ist mit Kohlenstoffdisulfid gefüllt - einer flüssigen chemischen Verbindung mit hoher optischer...

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Revolution der Rohre

Forscher*innen des Instituts für Sensor- und Aktortechnik (ISAT) der Hochschule Coburg lassen Rohrleitungen, Schläuchen oder Behältern in Zukunft regelrecht Ohren wachsen. Sie entwickelten ein innovatives akustisches Messverfahren, um Ablagerungen in Rohren frühzeitig zu erkennen.

Rückstände in Abflussleitungen führen meist zu unerfreulichen Folgen. Ein besonderes Gefährdungspotential birgt der Biofilm – eine Schleimschicht, in der...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

VideoLinks
Industrie & Wirtschaft
Veranstaltungen

Leben im Plastikzeitalter: Wie ist ein nachhaltiger Umgang mit Plastik möglich?

21.06.2018 | Veranstaltungen

Kongress BIO-raffiniert X – Neue Wege in der Nutzung biogener Rohstoffe?

21.06.2018 | Veranstaltungen

DFG unterstützt Kongresse und Tagungen im August 2018

20.06.2018 | Veranstaltungen

VideoLinks
Wissenschaft & Forschung
Weitere VideoLinks im Überblick >>>
 
Aktuelle Beiträge

Neue Phänomene im magnetischen Nanokosmos

22.06.2018 | Physik Astronomie

Roboter zeichnet Skizzen von Messebesuchern

22.06.2018 | Messenachrichten

Wärmestrahlung bei kleinsten Teilchen

22.06.2018 | Physik Astronomie

Weitere B2B-VideoLinks
IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics